Objective: Expansion of insulin-producing beta cells from adult human islets could alleviate donor shortage for cell-replacement therapy of diabetes. A major obstacle to development of effective expansion protocols is the rapid loss of beta-cell markers in the cultured cells. Here we report a genetic cell-lineage tracing approach for following the fate of cultured beta cells.
Results: Beta cells were efficiently and specifically labeled by the dual virus system. Labelpositive, insulin-negative cells derived from beta cells were shown to proliferate for a maximum of 16 population doublings, with an approximate doubling time of 7 days. Isolated labeled cells could be expanded in the absence of other pancreas cell types, if provided with medium conditioned by non-beta pancreatic cells. Analysis of mouse islet cells by the same method revealed a much lower proliferation of labeled cells under similar culture conditions.
Conclusions:
Our findings provide direct evidence for survival and dedifferentiation of cultured adult human beta cells, and demonstrate that the dedifferentiated cells significantly proliferate in vitro. The findings confirm the difference between mouse and human beta cell proliferation under our culture conditions. These findings demonstrate the feasibility of cell-specific labeling of cultured primary human cells, using a genetic recombination approach that was previously restricted to transgenic animals.
estoration of an adequate beta-cell mass is the central therapeutic goal in patients with type 1 diabetes. However, pancreatic islet transplantation is severely limited by the number of organ donors. Studies of adult islet renewal in vivo suggest that differentiated beta cells maintain a replication capacity (1) . However, success in expansion of functional insulin-producing beta cells in vitro has been limited. Culture of adult human islets resulted in a small number of cell population doublings and loss of insulin expression (2) (3) (4) (5) . Insulin-negative cells derived from such cultures could be induced to re-express insulin, however its levels were low and varied considerably among cells from different donors (6) (7) (8) . In the absence of stable markers for cultured beta cells it was not possible to determine whether the loss of beta-cell phenotype in the expanded cells reflected beta-cell dedifferentiation, or betacell death accompanied by expansion of islet cells from a non-beta-cell origin. Efficient expansion of dedifferentiated human beta cells in vitro could be of therapeutic significance, since these cells may retain enough of their specific open chromatin structure to facilitate their redifferentiation. Genetic cell-lineage tracing provided evidence for dedifferentiation of cultured mouse beta cells (9) , however it could not detect a significant proliferation of the dedifferentiated cells (9) (10) (11) (12) . Rather, under the culture conditions utilized, these cells were eventually eliminated, giving rise to cultures dominated by cells derived from non-beta cells. Here we applied a genetic cell-lineage tracing approach for following the fate of cultured adult human beta cells, using viral vector-mediated gene transfer. Our findings demonstrate that, in contrast to mouse beta cells, dedifferentiated human beta cells can be significantly expanded in culture.
RESEARCH DESIGN AND METHODS
Lentivirus vector construction and virus production: The pTrip RIP405 nlsCRE DeltaU3 (RIP-Cre) vector was generated by removing with BamHI and XhoI the eGFP coding region from the pTrip RIP405 eGFP DeltaU3 vector (13) , which contains a fragment of the rat insulin II gene from -405 to +7 relative to the transcription start site. The resulting linearized plasmid was bluntended with DNA polymerase I Klenow fragment. The reading frame A Gateway cassette (Gateway Conversion Kit, Invitrogen) was next ligated to the blunt ended vector according to manufacturer instructions, generating a pTrip RIP405 rfaGateway DeltaU3 destination vector. The nlsCRE fragment was amplified by PCR from a plasmid (14) kindly provided by Guilan Vodjdani using the forward primer 5'CACCAGATCTATGCCCAAGAAGAAG AGG3' and reverse primer 5'CTCGAGCTAATCGCCATCTTC3', and the resulting PCR product was cloned into the pENTR/D/TOPO plasmid (Invitrogen) to generate a nls-CRE entry clone. Both destination vector and entry clone were used for in vitro recombination using the LR clonase II system (Invitrogen) according to manufacturer instructions. The reporter vector was constructed by amplifying the loxPDsRed2-loxP cassette by PCR from a plasmid kindly provided by Isabelle Houbracken using the forward primer 5'AATTCACTAGTGAACCTCTTC3' and the reverse primer 5'GATCCGATCATATTCAATAA3'. The resulting PCR product was ligated into the blunt-ended BamHI site of the pTrip CMV eGFP DeltaU3 vector (13) Islets were received 2-3 days following isolation. Islets from individual donors were dissociated into single cells and cultured in CMRL 1066 medium containing 5.6 mM glucose and supplemented with 10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 100 µg/ml gentamycin, and 5 µg/ml amphotericine B as described (6) . Following 1-2 days in culture cells were washed with PBS and infected with a 1:1 mixture of the 2 viruses at MOI 3:1 in CMRL containing 8 µg/ml polybrene overnight. βTC-tet cells were infected at MOI 1.5:1. The medium was then replaced with regular culture medium. Cells were refed twice a week and split 1:2 once a week. Cell mortality rate was determined in 6-well plates by collecting floating cells 24-h following plating and staining with trypan blue. The adherent cells were trypsinized and similarly stained. Conditioned medium was obtained 2-3 days following the last change of medium, centrifuged at 1000 rpm for 4 min, filtered with a 0.22-µm filter, and stored at -20 o C. Mouse islets were isolated from 5-month-old BALB/c mice by collagenase infusion through the bile duct and treated similarly to the human islets. vimentin, Hs_00185584_m1; RPLP0, Hs_99999902_m1. All reactions were done in triplicates. The results were normalized to human large ribosomal protein P0 cDNA (RPLP0). Immunoblotting. Total protein was extracted by incubating cells for 10 min in 1% NP40 containing a protease inhibitor cocktail. Protein concentration was determined using the BCA Protein Assay Kit (Pierce). 40 µg protein were resolved on a SDS-PAGE gel.
The gel was electroblotted onto Immobilon-P Transfer Membrane (Milipore), followed by incubation with rabbit anti-cleaved poly(ADP-ribose) polymerase (PARP) (Cell Signaling, 1:1000) or rabbit anti-p21 (Santa Cruz, 1:200). Goat anti-actin (Santa Cruz, 1:1000) was used to monitor gel loading. The bound antibody was visualized with the appropriate horseradish peroxidaseconjugated anti-IgG and SuperSignal West Pico Chemiluminescent Substrate (Pierce). Cells treated with 1 µM staurosporine for 6 h were used as positive control. Statistical analysis. Significance was determined using a two-tailed Student's t test.
RESULTS
The labeling approach is based on cell infection with a mixture of 2 lentivirus vectors, one expressing Cre recombinase under control of the insulin promoter (RIPCre), and the other a reporter cassette with the structure CMV promoter-loxP-DsRed2-loxPeGFP ( Fig. 1 ). The latter virus expresses the fluorescent marker DsRed2 in all cells infected by it, while expression of enhanced green fluorescent protein (eGFP) is blocked. Removal of the DsRed2 coding sequence between the 2 loxP sites in beta cells infected by both viruses is expected to eliminate DsRed2 expression specifically in these cells and activate instead eGFP expression, which should allow continuous tracking of beta-cell fate after insulin expression is lost. Human beta cells were shown to maintain insulin expression during the initial days in culture (6), thereby providing a window of time for RIP-Cre expression. Non-beta cells infected with both viruses are expected to express only DsRed2.
The specificity of the labeling system was evaluated using the mouse beta-cell line βTC-tet, and 293T cells as a negative control. No eGFP + cells were detected in 293T cells infected with the reporter virus alone or with a mixture of the 2 viruses (Fig. 2) , demonstrating a tight inhibition of eGFP expression in the absence of RIP-Cre expression. This finding demonstrates the lack of non-specific RIP-Cre expression, such as could potentially be caused by virus integration next to a strong promoter, as well as a lack of GFP expression in the presence of the DsRed2 region. In contrast, Cre expression under CMV promoter resulted in efficient activation of eGFP expression. Presence of both eGFP and DsRed2 proteins in the same cells, manifested by yellow color, likely reflects the relatively long half-life of the DsRed2 protein (4.5 days), which may still be detected 1-2 weeks following loss of the DsRed2 gene and activation of eGFP expression. In βTC-tet cells infected with the reporter virus alone 61.2% of the cells became DsRed2 + , indicating a high efficiency of cell infection with this vector (based on >1000 cells counted in micrograph images; Fig. 3A) . In cells infected with the RIP-Cre virus alone, 100% of Cre + cells were also insulin-positive (Fig. 3B) . Given the infection efficiency with a single virus, in cells infected with both viruses the incidence of eGFP + and DsRed2 + cells is expected to be 37.4% (0.612X0.612) and 23.8% (0.612-0.374), respectively. The observed incidence was 32.3% and 30.6% for eGFP + and DsRed2 + , respectively (based on >1000 cells counted in micrograph images; Fig. 3A ). All eGFP + cells (100%) stained for insulin (Fig. 3C ).
Islets were isolated from 15 human donors, 10 males and 5 females, aged 17-60 (mean age 46±12), with a purity ranging between 70-90% (mean 78±6%), as determined by staining with dithizone (Supplementary Table 1 ). Islets from each donor were dissociated into single cells and cultured as described (6) . Since human islets were reported to contain on average 55% insulin-positive cells (15) , these preparations were expected to contain <43±3% insulinpositive cells at the time of isolation (0.55X0.78). After 1-2 days in culture the cells were infected with the reporter virus alone, or with a mixture of the 2 viruses. At the time of infection the number of insulinexpressing cells was expected to be lower, compared with their number immediately following isolation, due to rapid dedifferentiation during the 2-3 days of shipment and 1-2 days of initial culture (6) . Cells infected with the reporter virus alone showed DsRed2 expression in 68.2±11. Among eGFP + cells, 65.5%±7.1% were insulin-positive, and 68.9±8.9% were human C-peptide-positive, as judged by immunostaining following 5-6 days in culture (Fig. 5A) . This was the earliest time point (4-5 days following infection) at which eGFP could be clearly detected in live cells. A weak eGFP signal was detected earlier than 4-5 days post infection. However, it took a longer time for a strong signal to appear, probably due to accumulation of higher levels of eGFP in the cells. We waited for a strong, unequivocal, signal to appear before scoring the cells. To exclude insulin uptake, costaining for insulin and C-peptide was performed. 99.3±0.4% of the insulin-positive cells stained for C-peptide (based on counting 1000 cells from each of 3 donors following 5 days in culture), indicating that they were bona fide insulin-producing cells ( Supplementary Fig. 1 ). The insulin-negative eGFP + cells likely reflect a rapid loss of insulin content between the time of gene recombination and immunostaining (Fig 5A,  inset) . To further verify this possibility, cells were incubated following viral infection with 10 µM diazoxide, an inhibitor of insulin release (16) . This treatment resulted in an increase in the fraction of eGFP + cells that were insulin-positive to 84.8±5.8% (Fig. 5A) . It is possible that a higher concordance between insulin and eGFP could have been achieved by performing the labeling in the presence of lower glucose concentrations. However, we aimed at performing the labeling at 5.6 mM glucose, a concentration that was optimized for cell proliferation. The rate of insulin content loss at this concentration was expected to be moderate. Since Cre expression could be detected in the cells at an earlier time point following viral infection, compared with eGFP, the concordance between Cre and insulin expression was analyzed 36-h post-infection. The analysis revealed that 96.2±0.6% of the Cre + cells were insulin-positive (based on >1,000 cells counted from each of 3 donors). The concordance between Cre and C-peptide expression analyzed 21-h post-infection was even higher, with 98.2±0.6% of the Cre + cells staining for C-peptide (Fig. 4B) . The efficiency of beta-cell labeling, as judged by the percent of C-peptide-positive cells labeled with eGFP 4-5 days post-infection, was 57.5±8.9% (Fig. 5A) .
To evaluate the incidence of non-specific labeling of other pancreatic cells, the infected cells were stained with antibodies for 3 other islet hormones, as well as for amylase, a marker of pancreatic exocrine cells, and CK19, a marker of pancreatic duct cells. 11.3±7.6% of the eGFP + cells were stained for glucagon, accounting for 13.7±4.7% of glucagon-positive cells (Fig. 5A ). 1.0±0.6% of the eGFP + cells were stained for somatostatin, while 1.2±0.3% were pancreatic polypeptide (PP)-positive, accounting for 5.0±1.8% and 4.7±2.1% of the cells staining for each hormone, respectively. Human islets were reported to contain on average 38% glucagon-positive and 10% somatostatinpositive cells, respectively (15) . Co-staining with insulin showed that a large part of eGFP + cells expressing other islet hormones coexpressed insulin, indicating that their labeling by eGFP was specific, while the remainder may have expressed insulin at the time of viral infection, but had lost its expression during the time between infection and staining. Co-expression of islet hormones has been documented in human fetal islets (17, 18) , but not in adult islets. Its appearance in some cultured adult islet cells (Fig. 5C ) may represent a stage in cell dedifferentiation, in which the cells regress to a fetal-like phenotype. As shown in Fig. 5A, <0 .1% of amylase-or CK19-positive cells were stained with eGFP. Thus, the bulk of insulin-negative eGFP + cells did not stain for any of the other markers analyzed. All cells stained for the mesenchymal marker vimentin (data not shown), which was shown to be activated in all cultured islet cells (6) . Infection of cells at P7-8, at which no insulin-positive cells could be detected, with both viruses did not result in cell labeling with eGFP, providing further evidence for the dependence of transgene recombination on insulin expression (data not shown). Taken together, these findings demonstrate that the labeling of beta cells with eGFP in this system was efficient and specific.
The eGFP + cells were followed in the mixed cell population during continuous culture. As previously reported (6), the cultured islet cells replicated with an average doubling time of 7 days, as judged by cell counting, for up to 16 population doublings, before undergoing senescence. Cell mortality rate, documented in cells from 3 donors during the first 7 passages in culture, averaged 3.5% (1.0±0.8% of adherent cells were trypan blue-postitive, and in addition 2.5±1.9% of plated cells were nonadherent and trypan blue-postitive, 24 hours after plating). Thus, the plating efficiency was high, and most cells survived in culture. As seen in Fig. 6A , replicating eGFP + cells could be detected during the entire expansion period, as manifested by staining for Ki67 at P2, P4, P6, P12, and P14. At P2, 31.1±5.0% of eGFP + cells stained for Ki67. The proportion of eGFP + cells among cultured cells remained stable during this expansion period (Fig. 6B) , demonstrating that the doubling rate of the eGFP + cells was similar to that of eGFP-negative cells. Overall, replicating eGFP + cells were detected in multiple passages of islet cell cultures from 15/15 adult donors studied. The data was highly reproducible among all donors studied, and no age-or gender-related differences were noted. Taken together, these findings demonstrate that dedifferentiated beta cells survive and replicate for a considerable number of population doublings, and can be traced during this period by following the eGFP label.
These findings are in contrast to the inability to demonstrate continuous in-vitro proliferation of mouse beta cells labeled by transgenic approaches. We therefore utilized the viral labeling strategy to evaluate mouse beta-cell proliferation under conditions similar to those used for human cells. Isolated mouse islets were trypsinized and infected with the 2 lentiviruses. The efficiency of mouse beta-cell labeling ( Supplementary Fig.  2 ) was lower than that of human beta cells: 22.3±0.5%, compared with 57.5±8. 37%) were eGFP + , which is close to the incidence of 0.55% observed in the transgenic mouse islet cell cultures at that time point (9) . In contrast, the human islet cell culture at this time point consisted of 24.1±7.9% eGFP + cells (Fig. 6B ). These findings confirm the species difference between mouse and human beta cell proliferation under our culture conditions. eGFP + and DsRed2 + cells from the human islet cultures were sorted by FACS and analyzed for transgene recombination and gene expression (Fig. 7A) . DNA analysis of the sorted cells detected the recombined gene only in eGFP + cells, while DsRed2 + cells contained only the original gene (Fig. 7B) . Quantitative RT-PCR analysis of RNA extracted from eGFP + and DsRed2 + cells at P2 and P12 documented the enrichment of beta-cell markers in eGFP + , compared with DsRed2 + cells, at P2, and the dedifferentiation of eGFP + cells by P12 (Table 1) . However, transcript levels in eGFP + cells at P2 were 5-37-fold lower, compared with the unsorted islet cell population at P0. Glucagon transcripts were detectable in eGFP + cells, confirming the immunofluorescence results (Fig. 5) , however they were enriched in
DsRed2
+ cells. Low levels of insulin, PC2, glucagon, and PAX6 transcripts were still detectable in eGFP + cells at P12, however all other beta-cell transcripts were not detected at this stage. Transcripts for PTF1a, HNF6, and NGN3, which are expressed during pancreas development, were not detected in any of the samples.
We next analyzed the replication capacity of sorted eGFP + cells. Compared with a doubling time of 7 days in the mixed population, eGFP + cells sorted at P8 with a purity >90% grew very slowly and doubled approximately once in 4 weeks. Supplementing the culture medium with 50% medium conditioned for 2 days by the mixed islet cell population at P0, or for 3 days by P10 DsRed2
+ cells sorted at P8, resulted in a decrease in the doubling time to 9 and 10 days, respectively. The doubling time of FACS-sorted DsRed2 + cells remained 7 days. eGFP + cells sorted at P8 could be propagated for 8 population doublings in the presence of conditioned medium before ceasing to replicate, representing a 256-fold expansion. Growth arrest was not associated with detectable apoptosis, as judged by immunoblotting analysis for cleaved poly(ADP-ribose) polymerase (PARP) (Fig.  7C) . In contrast, p21, a protein involved in replicative senescence induced by telomere shortening (19) , was upregulated in cells in the terminal passages (Fig. 7C) . In contrast to high-purity sorted eGFP + cells, sorted eGFP + cells with a purity <80% grew equally well in the presence or absence of conditioned medium, indicating that the residual non-beta cells remaining in those preparations were sufficient for conditioning the medium. eGFP + cells sorted at P5-8 could be stained for Ki67 at multiple subsequent passages (Fig.  7D) . Taken together these results suggest that the eGFP-negative cells secrete growth factor(s) needed for proliferation of eGFP + cells, and that the sorted eGFP + cells become senescent around P16. This number of passages represents a theoretical overall expansion of 65,536-fold.
DISCUSSION
Our findings provide for the first time direct evidence for survival and dedifferentiation of cultured adult human beta cells. In addition, they demonstrate that the dedifferentiated cells can significantly proliferate in vitro. Dedifferentiation may be a precondition for beta-cell proliferation in vitro, as evidenced by the scarcity of insulin + /Ki67
+ cells in early passages of human islet cell cultures (6) . However, dedifferentiation may not be sufficient for inducing beta-cell proliferation, as evidenced by the limited replication of dedifferentiated mouse beta cells. The ability to purify human beta cells following genetic labeling in vitro will allow detailed studies of the molecular mechanisms involved in these two processes. In addition to replicating cells derived from beta cells, the islet cell cultures contain replicating cells which are not labeled with eGFP. Some of these cells may also be derived from beta cells, which were infected with only one or none of the 2 viruses. However, the majority of these cells are likely to be derived from other cellular origins, such as connective tissue in the islets or contaminating ductal tissue in the islet preparation. Nevertheless, our findings show that cells derived from beta cells can be isolated and expanded in the absence of other cell types present in the islet cell culture, provided that their culture medium is supplemented with medium conditioned by non-beta cells. The factors released by these cells, which affect beta-cell growth, are of great interest, and the labeling system provides a convenient assay for their characterization. This system is also suitable for high-throughput screening of compound libraries for identification of agents which may further stimulate replication of the dedifferentiated beta cells in culture, as well as induce redifferentiation of the expanded cells.
Our work demonstrates the feasibility of cell-specific labeling of cultured primary human cells, using a genetic recombination approach that was previously restricted to transgenic animals. Despite the rapid dedifferentiation of beta cells in culture, virus integration into the genome and expression of the Cre recombinase under a beta-cell-specific promoter are apparently fast enough to allow efficient DNA recombination before dedifferentiation occurs, resulting in a remarkable efficiency of beta-cell labeling with this system (57.5±8.9% of the C-peptidepositive cells following 5-6 days in culture). It should be noted that the cell-specificity of this system relies on the use of a fragment of the regulatory region of the rat insulin II gene (-405 to +7 relative to the transcription start site), which is expected to allow Cre expression only in beta cells. However, while this region was shown in numerous studies to contain the major regulatory elements required for beta-cell-specific expression, it is possible that additional elements in the intact insulin gene locus are involved in determining tight cell-specificity. Thus, it can not be excluded that the absence of such elements in the RIP-Cre construct may result in its expression in a broader range of cells than bona fide mature beta cells.
Previous work has shown that proliferating cells expanded from cultured adult human islets contain cells expressing mesenchymal markers. Initially it was suggested that these cells originated from beta cells through epithelial-to-mesenchymal transition (EMT) (7) . Recent work has documented the expression of mesenchymal stem cell (MSC) markers on these cells, and their ability to differentiate into osteocytes and adipocytes (20, 21) , however their cellular origin has not been rigorously established. Using the labeling system described here it should be possible to determine if these cells are generated from beta cells by EMT or represent MSCs originally present in the islets. The proliferation of dedifferentiated human beta cells in culture is in contrast with the limited proliferative capacity of mouse beta cells cultured under the same conditions. It is possible that the culture media employed in this and previous (9-12) studies with mouse islet cell cultures lack components needed for a significant expansion of mouse beta cells, while they are supportive for human beta-cell proliferation. Further investigation of this difference between mouse and human beta cells may provide new insights into the mechanisms that regulate beta-cell replication. 
